Compare Global E Online Ltd (GLBE) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global E Online Ltd vs Illumina, Inc. — how do they compare? Global E Online Ltd trades at $38.39 (market cap $6.55B), while Illumina, Inc. trades at $189.05 (market cap $28.32B). The key difference: Illumina, Inc. is far larger — about 4.3× Global E Online Ltd's market cap, and Illumina, Inc. is trading nearer its 52-week high, Global E Online Ltd nearer its low. Which is the better fit depends on your goals.
| GLBE | ILMN | |
|---|---|---|
Market Cap | $6.55B | $28.32B |
Sector | Technology | Health |
52-Week High | $41.59 | $194.33 |
52-Week Low | $27.54 | $91.00 |
Enterprise Value | $6.02B | $29.70B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLBE trades at $38.43, down 0.84% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 results with 33% revenue growth and raised its full-year outlook. Recent acquisition of Passport aims to enhance logistics capabilities. Valuation ratios are elevated with a P/E of 58.18, reflecting high growth expectations.
Outlook remains positive driven by merchant expansion and cross-border e-commerce growth, but high valuation poses a risk if growth slows. Analyst consensus is unanimously bullish with a $38 price target, though recent insider sales and mixed quarterly EPS performance warrant monitoring.
Illumina (ILMN) trades at $188.27, down 1.53% on the day, yet maintains a strong technical and fundamental posture. The stock is in a bullish trend, supported by consistent earnings beats, robust profitability margins, and positive analyst sentiment. Recent news highlights strong momentum in 2026, driven by sequencing demand and new product launches, positioning the company for growth despite competitive pressures.
The outlook for ILMN is positive, with earnings growth and market leadership in genomics offering upside potential. Key risks include intensifying competition from new entrants like Roche and execution challenges in a dynamic healthcare landscape. Investor sentiment remains buoyant, but vigilance on competitive threats and margin sustainability is warranted for sustained performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Global E Online Ltd
Global-e provides a platform for cross-border e-commerce, helping retailers increase international sales by localizing the shopping experience for consumers in over 200 destinations worldwide.
Read more on GLBE →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
